US-based private equity firm Carlyle Group is set to acquire a minority stake in Hyderabad-based vaccine manufacturer Bharat Biotech International Ltd, according to two people familiar with the development. The investment, which will be made through Carlyle Asia Growth Partners, is around Rs250-300 crore, said one of the two, asking not to be identified. The size of the stake being acquired isn’t known.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
